Document Detail

New Anticoagulants in Ischemic Heart Disease.
MedLine Citation:
PMID:  22528556     Owner:  NLM     Status:  Publisher    
Historically, the use of oral anticoagulants in acute coronary syndromes (ACS) has been controversial. Several prospective trials have shown that vitamin K antagonists (VKAs), such as warfarin or dicoumarol, reduce recurrent ischemic events but with a concomitant increased risk of bleeding. Other trial data have shown a neutral or net negative effect. Regardless, these prior observations are not readily transposable to contemporary practice where many ACS patients receive dual antiplatelet therapy and undergo cardiac catheterization and percutaneous coronary intervention. Because recurrent ischemic events continue to occur following index ACS presentation despite evidence-based practice and knowing the limitations of current oral anticoagulation strategies with VKA, the endeavor continues to find a more effective anticoagulant with predictable, dose-proportional pharmacokinetics, and minimal interactions with food and drugs. We review novel, emerging classes of anticoagulants that focus on specific targets in the coagulation cascade with the aim of improving long-term net clinical outcomes.
Lawrence Rajan; David J Moliterno
Related Documents :
22666796 - Hypoxia/reoxygenation-induced myocardial lesions in newborn piglets are related to inte...
691276 - Changes in ventricular recovery properties during and after temporary coronary artery o...
3571746 - Intermittent coronary sinus occlusion in dogs: reduction of infarct size 10 days after ...
6894846 - Early pathologic detection of acute myocardial infarction.
9628446 - Pharmacology of the low-molecular-weight heparins.
8513546 - Noninvasive risk assessment after myocardial infarction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-22
Journal Detail:
Title:  Current cardiology reports     Volume:  -     ISSN:  1534-3170     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, 900 S. Limestone Street 329 Wethington Building, Lexington, KY, 40536-0200, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Baroreflex activation for the treatment of heart failure.
Next Document:  Preservation of Myocardium During Coronary Artery Bypass Surgery.